Suppr超能文献

一项旨在了解全球疫苗总体信任度、新冠疫苗和流感疫苗信心的调查。

A global survey to understand general vaccine trust, COVID-19 and influenza vaccine confidence.

作者信息

D'Silva Chelsea, Fullerton Madison M, Hu Jia, Rabin Kenneth, Ratzan Scott C

机构信息

19 to Zero Inc, Calgary, AB, Canada.

Community Health Sciences, University of Calgary, Calgary, AB, Canada.

出版信息

Front Public Health. 2024 Nov 20;12:1406861. doi: 10.3389/fpubh.2024.1406861. eCollection 2024.

Abstract

INTRODUCTION

The COVID-19 pandemic has greatly impacted the way that the world views vaccines. While safe and effective, COVID-19 vaccines were, and continue to be met with hesitancy and misinformation. We aimed to understand public perceptions and trust in COVID-19 vaccinations and how the pandemic has impacted perceptions of non-COVID-19 vaccines.

METHODS

Survey data were collected between August 7, 2023-August 16, 2023, from 7,000 respondents aged 18 years and older from the United States ( = 1,000); Nigeria ( = 1,000); United Kingdom ( = 1,000); France ( = 1,000); Canada ( = 1,000); Brazil ( = 1,000); and India ( = 1,000).

RESULTS

Trust in COVID-19 vaccines was highest in Brazil (84.6%) and India (80.4%) and lowest in the United States (63.5%) and France (55.0%). 47.5% of respondents agreed that they trust traditional protein-based vaccines more than mRNA vaccines, 13.5% disagree and 39.0% are neutral about their trust in protein-based versus mRNA vaccines. Overall, 53.9% of respondents reported that the COVID-19 pandemic impacted their perceptions of vaccines with half of these respondents (51.7%) reporting that the pandemic made them think that other vaccines are more important as they understand how critical vaccines can be at preventing serious illnesses.

DISCUSSION

These data can be used by health system decision makers, public health and researchers to understand how vaccine trust impacts perceptions of COVID-19 and influenza vaccines globally and develop tailored interventions that address local concerns.

摘要

引言

新冠疫情极大地影响了全球对疫苗的看法。尽管新冠疫苗安全有效,但过去和现在都面临着犹豫和错误信息。我们旨在了解公众对新冠疫苗接种的认知和信任,以及疫情如何影响了对非新冠疫苗的看法。

方法

于2023年8月7日至2023年8月16日收集调查数据,来自美国(n = 1000)、尼日利亚(n = 1000)、英国(n = 1000)、法国(n = 1000)、加拿大(n = 1000)、巴西(n = 1000)和印度(n = 1000)的7000名18岁及以上的受访者参与。

结果

对新冠疫苗的信任度在巴西最高(84.6%)和印度(80.4%),在美国最低(63.5%)和法国(55.0%)。47.5%的受访者同意他们更信任传统的基于蛋白质的疫苗而非mRNA疫苗,13.5%不同意,39.0%对基于蛋白质的疫苗和mRNA疫苗的信任持中立态度。总体而言,53.9%的受访者表示新冠疫情影响了他们对疫苗的看法,其中一半的受访者(51.7%)表示疫情使他们认为其他疫苗更重要,因为他们明白了疫苗在预防严重疾病方面的关键作用。

讨论

卫生系统决策者、公共卫生人员和研究人员可以利用这些数据来了解疫苗信任如何在全球范围内影响对新冠和流感疫苗的看法,并制定针对性的干预措施来解决当地的担忧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fde/11615073/27bac484bf58/fpubh-12-1406861-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验